WTC PTSD linked to multisystem proteomic aging and metabolic shifts 18 years post-9/11

The Stony Brook–Duke study performed targeted metabolomics and proteomics on blood drawn nearly two decades after exposure. PTSD-positive responders exhibited coordinated dysregulation across extracellular matrix, innate immunity, and mitochondrial redox modules, patterns previously documented in smaller veteran cohorts but here quantified at scale with organ-enriched protein signatures. These changes align with elevated incidence of metabolic and pulmonary disease already tracked in the WTC Health Program registry, extending beyond self-reported symptoms.

Prior WTC reports focused on psychiatric prevalence or single-disease endpoints; this work supplies mechanistic intermediates that connect trauma to measurable declines in pancreatic and lung protein clocks. Funding from NIOSH and the CDC WTC program reduces some conflicts, yet residual healthy-survivor bias in the monitored cohort remains unquantified. Cross-sectional design precludes causal ordering between PTSD onset and molecular changes.

Next steps require longitudinal sampling of the same individuals to test whether proteomic age acceleration predicts incident diabetes or COPD at rates exceeding trauma-exposed controls by at least 15 percentage points within five years. Integration with epigenetic clocks would further clarify whether the observed shifts represent reversible stress embedding or fixed cellular senescence.